Transfemoral Aortic Valve Implantation with the New Edwards Sapien 3 Valve for Treatment of Severe Aortic Stenosis—Impact of Valve Size in a Single Center Experience

AIMS: The third generation Edwards Sapien 3 (Edwards Lifesciences Inc., Irvine, California) system was optimized to reduce residual aortic regurgitation and vascular complications. METHODS AND RESULTS: 235 patients with severe symptomatic aortic stenosis were prospectively enrolled. Transcatheter ao...

Descripción completa

Detalles Bibliográficos
Autores principales: Wöhrle, Jochen, Gonska, Birgid, Rodewald, Christoph, Seeger, Julia, Scharnbeck, Dominik, Rottbauer, Wolfgang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803290/
https://www.ncbi.nlm.nih.gov/pubmed/27003573
http://dx.doi.org/10.1371/journal.pone.0151247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803290/
https://www.ncbi.nlm.nih.gov/pubmed/27003573
http://dx.doi.org/10.1371/journal.pone.0151247

Ejemplares similares